Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution
Huachun Cui, Dingyuan Jiang, Sami Banerjee, Na Xie, Tejaswini Kulkarni, Rui-Ming Liu, Steven R. Duncan, Gang Liu
Huachun Cui, Dingyuan Jiang, Sami Banerjee, Na Xie, Tejaswini Kulkarni, Rui-Ming Liu, Steven R. Duncan, Gang Liu
View: Text | PDF
Research Article Pulmonology

Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution

  • Text
  • PDF
Abstract

Recent studies have presented compelling evidence that it is not tissue-resident, but rather monocyte-derived alveolar macrophages (TR-AMs and Mo-AMs, respectively) that are essential to development of experimental lung fibrosis. However, whether apolipoprotein E (ApoE), which is produced abundantly by Mo-AMs in the lung, plays a role in the pathogenesis is unclear. In this study, we found that pulmonary ApoE was almost exclusively produced by Mo-AMs in mice with bleomycin-induced lung fibrosis. We showed that, although ApoE was not necessary for developing maximal fibrosis in bleomycin-injured lung, it was required for the resolution of this pathology. We found that ApoE directly bound to Collagen I and mediated Collagen I phagocytosis in vitro and in vivo, and this process was dependent on low-density lipoprotein receptor–related protein 1 (LPR1). Furthermore, interference of ApoE/LRP1 interaction impaired the resolution of lung fibrosis in bleomycin-treated WT mice. In contrast, supplementation of ApoE promoted this process in ApoE–/– animals. In conclusion, Mo-AM–derived ApoE is beneficial to the resolution of lung fibrosis, supporting the notion that Mo-AMs may have distinct functions in different phases of lung fibrogenesis. The findings also suggest a potentially novel therapeutic target for treating lung fibrosis, to which effective remedies remain scarce.

Authors

Huachun Cui, Dingyuan Jiang, Sami Banerjee, Na Xie, Tejaswini Kulkarni, Rui-Ming Liu, Steven R. Duncan, Gang Liu

×

Figure 8

Exogenous ApoE promotes the resolution of pulmonary fibrosis.

Options: View larger image (or click on image) Download as PowerPoint
Exogenous ApoE promotes the resolution of pulmonary fibrosis.
(A) Six-we...
(A) Six-week-old ApoE–/– male mice were i.t. instilled with saline or bleomycin (BLM, 1.5 U/kg in 50 μL saline). Starting at 4 weeks after bleomycin treatment, mice were treated i.t. ApoE (1 μg in 50 μL saline) or saline alone, once every other day. Mice were eventually sacrificed at 8 weeks after bleomycin injection for lung harvesting. (B) The levels of hydroxyproline in the lungs were determined. n = 4, 8, 6 mice for BLM–ApoE–, BLM+ApoE–, and BLM+ApoE+, respectively; mean ± SEM; *P < 0.05, ***P < 0.001 by 1-way ANOVA with Bonferroni’s post hoc test. (C) Total RNA of the lungs was purified and the expression of the indicated genes was assessed by real-time PCR. n = 4, 8, 6 mice for BLM–ApoE–, BLM+ApoE–, and BLM+ApoE+, respectively; mean ± SEM; *P < 0.05, ***P < 0.001 by 1-way ANOVA with Bonferroni’s post hoc test. (D and E) BALF protein was precipitated and resolved by SDS-PAGE. Levels of the indicated proteins in BALF were determined by Western blotting (D) and densitometric analyses performed using ImageJ (E). n = 5, 5 for Vehicle and ApoE, respectively; mean ± SEM; ***P < 0.01 by 2-tailed Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts